Navigation Links
Orexigen Resubmits Contrave New Drug Application
Date:12/11/2013

risk profile for Contrave; and the execution of the Contrave U.S. launch by Takeda; Orexigen's plans to seek a commercialization partner in territories outside of North America; and the timing of the submission of the CSR for the interim analysis. The inclusion of forward‐looking statements should not be regarded as a representation by Orexigen that any of its plans will be achieved. Actual results may differ materially from those expressed or implied in this release due to the risk and uncertainties inherent in the Orexigen business, including, without limitation: the possibility that the FDA determines not to initiate review of the Contrave NDA until it has received the CSR for the interim analysis; the SPA is not binding on the FDA if public health concerns unrecognized at the time the SPA agreement was entered into become evident, other new scientific concerns regarding product safety or efficacy arise, or if Orexigen fails to comply with the agreed upon trial protocol; the potential for the FDA to not approve Contrave even after meeting the prespecified threshold and resubmitting the NDA; the possibility that public disclosure of the results of the interim analysis would later be deemed to jeopardize the integrity of the Light Study potentially resulting in the requirement to conduct additional, costly studies; additional analysis of the interim results or new data from the continuing Light Study, including safety-related data, may produce negative or inconclusive results, or may be inconsistent with the conclusion that the interim analysis was successful; the potential that the interim analysis may not be predictive of future results in the Light Study; the potential for early termination of Orexigen's North American collaboration agreement with Takeda; the results from the interim analysis may not be sufficient to satisfy or respond to the Day 120 List of Questions from the EMA or any other data requirements of the EMA in conn
'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Orexigen Therapeutics, Inc. Announces the Closing of its Offering of $115 Million of Convertible Senior Notes
2. Orexigen Therapeutics to Present at the 25th Annual Piper Jaffray Healthcare Conference
3. Orexigen Announces Successful Interim Analysis of Contrave Light Study
4. Orexigen Therapeutics to Host Contrave Light Study Interim Analysis Conference Call and Webcast
5. Orexigen Therapeutics Reports Business and Financial Results for the Third Quarter Ended September 30, 2013
6. Orexigen and Takeda Announce Multiple Contrave Data Presentations at the ObesityWeek Meeting in Atlanta
7. Orexigen Therapeutics Enters Into Agreement with Sanofi to Manufacture Contrave for Territories Outside North America
8. A Balanced Risk-Benefit Profile Will Propel Orexigen/Takedas Contrave to Become the Most Widely Used Emerging Therapy for the Treatment of Obese and Overweight Patients
9. Orexigen Therapeutics Announces Date of Third Quarter 2013 Financial Results Conference Call and Upcoming Presentation at Credit Suisse Healthcare Conference
10. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch Global Healthcare Conference
11. Orexigen Therapeutics Announces European Filing Strategy and Reports Business and Financial Results for the Second Quarter Ended June 30, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Research and Markets  has announced the addition of the ... Global Market Report of Pralmorelin (CAS 158861-67-7) ... ( Europe , Asia , ... etc.). It captures Pralmorelin market trends, pays close ... primary areas; manufacture methods & technology development, market situation & ...
(Date:8/20/2014)... Reportlinker.com announces that a new market ... Global Coatings for Medical Devices Industry ... This report analyzes the worldwide markets for Coatings ... following Product Segments: Active Coatings, Protective Coatings, Optical ... comprehensive analytics for the US, Canada ...
(Date:8/20/2014)... SALT LAKE CITY , Aug. 20, 2014 /PRNewswire/ ... their revolutionary mobile diagnostic platform during a special event ... City, Utah , on September 5, 2014. The ... be LiveStreamed on the ApolloDx website, www.apollodx.com .  ... will transform diagnostic testing," said Jared Bauer , ...
Breaking Medicine Technology:Global Market Report of Pralmorelin 2Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21
... among most serious injuries to childrenLAS VEGAS, Feb. 25 ... joint infections, a hip problem known as slipped epiphysis, ... problems and other complications if children are not treated ... released today at the 2009 Annual Meeting of the ...
... Cincinnati Children,s Hospital Medical Center has received a ... Foundation to help prevent flu in pregnant women and ... Most childhood deaths occur in the first hours and ... infections. In developing countries, where many births happen ...
Cached Medicine Technology:Children and Orthopaedic Surgical Emergencies 2Children and Orthopaedic Surgical Emergencies 3Children's Hospital Receives $6.7 Million Grant From Gates Foundation to Study Influenza Vaccine in Pregnant Women in Asia 2
(Date:8/20/2014)... is now, Free content, The time to deploy ... being published early online today in Annals ... School of Public Health write that the relentless epidemiologic ... represent a public health crisis that shows no signs ... been developed in the last decade, yet the sporadic ...
(Date:8/20/2014)... By Dennis Thompson ... -- Regular exercise may help older women avoid a condition ... Physically active postmenopausal women had a 10 percent lower ... more sedentary, researchers report in the Aug. 20 issue of ... Active women enjoyed this protection against the heart rhythm disorder ...
(Date:8/20/2014)... persistent and deadliest infectious diseases in the world, killing ... who study tuberculosis have long debated its origins. New ... Africa to seals and sea lions that brought the ... people there before Europeans landed on the continent. , ... Source of New World Human Tuberculosis," was published in ...
(Date:8/20/2014)... Researchers have found a novel approach to treating cancer ... August edition of Science Translational Medicine shows ... signals sent by nerves that are linked to cancer ... use of Botox made the treatment cheap, safe and ... on mice, and will soon start testing on humans. ...
(Date:8/20/2014)... Quincy Bioscience, a Wisconsin-based biotech company, has been ... fastest growing private companies in the nation , for ... Bioscience is honored again to be grouped with the ... Bioscience is manufacturer of Prevagen brand supplements, which contain ... in jellyfish and clinically shown to improve memory. Sales ...
Breaking Medicine News(10 mins):Health News:News from Annals of Internal Medicine 2Health News:Exercise May Guard Against Irregular Heartbeat in Older Women 2Health News:Exercise May Guard Against Irregular Heartbeat in Older Women 3Health News:New research shows seals and sea lions likely spread tuberculosis to humans 2Health News:New research shows seals and sea lions likely spread tuberculosis to humans 3Health News:Treating gastric cancer -- with Botox 2Health News:Quincy Bioscience Recognized in Inc. 500|5000 List of America’s Fastest Growing Companies for Third Consecutive Year 2
... proposed to initiate mass-production of a live bird flu vaccine ... the start of next year // in China. This ... a vaccine for humans. ,More than 1-billion ... the year-end. This would be a supplement to the already ...
... waves had left over 25,000 people dead and many more ... Indian Ocean countries. // One in five Thai ... that forever changed the physical, social and psychological landscape of ... interviews, an average of 20 percent of Thai tsunami survivors ...
... will make women more empowered. They have now developed ... completely.,The pill developed by New Jersey-based Wyeth and called ... and the inconvenience of periods. ,Critics have warned ... and breast cancer. They said continuous exposure to hormones ...
... give a false picture about coma survival and recovery rates ... felt // by coma patients and found that the ... not true as the study show that only 8% of ... with 50% upwards in real life. ,The recovery ...
... by researchers at Washington University School of Medicine in St. ... rapidly after treatment and are not as depressed as some ... of this study appear in the December issue of Supportive ... underwent radiation therapy at Siteman Cancer Center at Washington University ...
... picture of coma patients' survival and recovery, with potentially important ... storylines containing coma patients over 10 years, researchers found that ... coma than in real life. And they were also much ... of soap land patients died during coma, compared with over ...
Cached Medicine News:
Binkhorst, length 35 mm....
Army navy retractor set....
Rigid neck rake retractor, 3 sharp prong....
Rees bayonet forceps, standard, 5-1/2", TC....
Medicine Products: